Amarin Corporation plc AMRN

Updated: 10 Aug 2026

NASDAQ | Biotech | Cardiovascular pharmaceuticals

No signal published yet

We already track Amarin and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Amarin free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Cardiovascular pharmaceuticals
We're already tracking Amarin Corporation plc — here are the latest events we've registered

Recent News

  • On July 29, 2026, Amarin reported its second-quarter 2026 financial results, posting total net revenue of $42.2 million and generating positive operating cash flow for the third consecutive quarter. The company ended the quarter with $314.6 million in cash and short-term investments and zero debt. European in-market demand for VAZKEPA increased 69% year-over-year during the quarter under its international commercial partnership model.

What Firelda Watch includes for Amarin Corporation plc

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Amarin Corporation plc will be delivered in the same format.

Want to follow Amarin Corporation plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Amarin free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Amarin Corporation plc AMRN
Amarin — follow and we'll monitor it
Follow Amarin free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.